SARS-CoV-2-IN-13
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-144770-5MG | 5 mg | 204,00 | Add | |
| HY-144770-1ML | 10mM/1mL | 222,00 | Add | |
| HY-144770-10MG | 10 mg | 317,00 | Add | |
| HY-144770-25MG | 25 mg | 621,00 | Add | |
| HY-144770-50MG | 50 mg | 964,00 | Add | |
| HY-144770-100MG | 100 mg | 1'534,00 | Add | |
| HY-144770-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
SARS-CoV-2-IN-13 (compound 5) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.057 μM. SARS-CoV-2-IN-13 is a niclosamide analogue. SARS-CoV-2-IN-13 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally[1].
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Infection, Anti-infection |
| Format | Solubility: DMSO : ≥ 125 mg/mL |
| Grade | Clinical information: No Development Reported |
| Purity | 98.9% |
| Molecular Formula | C13H8Cl2N2O4 |
| Molecular Weight | 327.12 |
| CAS-Number | 56961-10-5 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Product Line | Coronavirus |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
